Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
April 3, 1992
Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives
H J Wadsworth, S M Jenkins, B S Orlek, et al.
Journal of Viral Hepatitis
|
November 13, 2020
Utilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan
Eileen M Weinheimer-Haus, Xianshi Yu, Amit G Singal, et al.
Journal of Medicinal Chemistry
|
January 22, 1998
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere
S M Bromidge, F Brown, F Cassidy, et al.
Nutrients
|
February 24, 2024
Design of a Remote Time-Restricted Eating and Mindfulness Intervention to Reduce Risk Factors Associated with Early-Onset Colorectal Cancer Development among Young Adults
Manoela Lima Oliveira, Alana Biggers, Vanessa M Oddo, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 17, 2024
Design of a mindfulness intervention to reduce risk factors for colorectal cancer among at-risk Black women in Chicago
Manoela Lima Oliveira, Natalia Salvatierra Lima, Garcelle Khara Renaud, et al.
International Journal of Environmental Research and Public Health
|
November 24, 2023
Mi-CARE: Comparing Three Evidence-Based Interventions to Promote Colorectal Cancer Screening among Ethnic Minorities within Three Different Clinical Contexts
Karriem S Watson, Katherine Y Tossas, Yazmin San Miguel, et al.
Journal of Medicinal Chemistry
|
November 14, 1997
6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist
S M Bromidge, M Duckworth, I T Forbes, et al.
Perfusion
|
May 4, 2001
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction
M B Patel, K S Kilgore, G A Ortolano, et al.
Journal of Medicinal Chemistry
|
December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists
I T Forbes, S Dabbs, D M Duckworth, et al.
Journal of Bacteriology
|
January 22, 2005
Growth kinetics of extremely halophilic archaea (family halobacteriaceae) as revealed by arrhenius plots
Jessie L Robinson, Brandy Pyzyna, Rachelle G Atrasz, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
April 3, 1992
Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives
H J Wadsworth, S M Jenkins, B S Orlek, et al.
Journal of Viral Hepatitis
|
November 13, 2020
Utilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan
Eileen M Weinheimer-Haus, Xianshi Yu, Amit G Singal, et al.
Journal of Medicinal Chemistry
|
January 22, 1998
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere
S M Bromidge, F Brown, F Cassidy, et al.
Nutrients
|
February 24, 2024
Design of a Remote Time-Restricted Eating and Mindfulness Intervention to Reduce Risk Factors Associated with Early-Onset Colorectal Cancer Development among Young Adults
Manoela Lima Oliveira, Alana Biggers, Vanessa M Oddo, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 17, 2024
Design of a mindfulness intervention to reduce risk factors for colorectal cancer among at-risk Black women in Chicago
Manoela Lima Oliveira, Natalia Salvatierra Lima, Garcelle Khara Renaud, et al.
International Journal of Environmental Research and Public Health
|
November 24, 2023
Mi-CARE: Comparing Three Evidence-Based Interventions to Promote Colorectal Cancer Screening among Ethnic Minorities within Three Different Clinical Contexts
Karriem S Watson, Katherine Y Tossas, Yazmin San Miguel, et al.
Journal of Medicinal Chemistry
|
November 14, 1997
6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist
S M Bromidge, M Duckworth, I T Forbes, et al.
Perfusion
|
May 4, 2001
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction
M B Patel, K S Kilgore, G A Ortolano, et al.
Journal of Medicinal Chemistry
|
December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists
I T Forbes, S Dabbs, D M Duckworth, et al.
Journal of Bacteriology
|
January 22, 2005
Growth kinetics of extremely halophilic archaea (family halobacteriaceae) as revealed by arrhenius plots
Jessie L Robinson, Brandy Pyzyna, Rachelle G Atrasz, et al.
Page
of 12